Back to explore
Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial
1 Assessments
0 Serious · 1 Some · 0 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV013 Clinical Chair in Health Services Research | 16 Nov 2025 | No | No | Unclear | No | Some concerns | View |
Publication Details
Journal
BMJ
Publisher
BMJ
Published
11 Sept 2025
ISSN / eISSN
1756-1833